BrightInsight

Executive Summary

BrightInsight provides a regulated cloud platform that enables biopharma and medtech companies to build, launch, and scale compliant digital health solutions, including companion apps, connected devices, and Software as a Medical Device (SaMD). Founded in 2017 and headquartered in San Jose, the company addresses a critical need for accelerating time-to-market while ensuring regulatory compliance across global markets. Its platform aims to deliver measurable clinical and business ROI for flagship therapeutic brands, positioning itself as a key enabler in the rapidly growing digital health sector. With the increasing adoption of SaMD and connected devices in healthcare, BrightInsight is well-positioned to capture demand from pharmaceutical and medical device companies seeking to integrate digital therapeutics and remote monitoring solutions. However, its competitive landscape includes established players and emerging startups, and the company's growth depends on expanding its client base and achieving scale.

Upcoming Catalysts (preview)

• Q3 2026Major Biopharma Partnership Announcement70% success
• Q4 2026FDA Clearance of a SaMD Built on BrightInsight's Platform60% success
• Q1 2027Series C Funding Round to Accelerate Expansion65% success